If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
Represents (i) 3,295,183 shares of common stock, par value $0.001 per share ("Common Stock"), (ii) 61,431 shares of Common Stock, issuable upon settlement of deferred restricted stock units ("RSUs"), (iii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Convertible Preferred Stock, par value $0.001 ("Series C Preferred Stock"), (iv) 3,286,825 shares of Common Stock that were acquired in connection with the Combination (as defined and disclosed in Item 4) and (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination. Such shares of Common Stock represent approximately 63.7% of the Issuer's outstanding Common Stock, assuming settlement of the deferred RSUs held by the Reporting Persons and the exchange of all Series C Preferred Stock held by the Reporting Persons into shares of Common Stock, in accordance with Rule 13d-3 of the Act. However, pursuant to the Certificate of Designations of Series C Convertible Preferred Stock (the ''Certificate of Designations''), no holder of Series C Preferred Stock may convert Series C Preferred Stock in an amount that would cause such holder to beneficially own immediately following such conversion more than 49.99% of the then outstanding shares of Common Stock. Pursuant to the Certificate of Designations, to the extent that the Series C Preferred Stock and any shares of Common Stock held by the Reporting Person, together with certain transferees and affiliates, would represent voting rights with respect to more than 33.32% of the Common Stock (including the Series C Preferred Stock on an as-converted basis) (the ''Voting Threshold''), such Reporting Person will not be permitted to exercise the voting rights with respect to any shares of Series C Preferred Stock held by them in excess of the Voting Threshold and the Issuer shall exercise the voting rights with respect to such shares of Series C Preferred Stock in excess of the Voting Threshold in a neutral manner. Calculated based on 15,184,326 shares of Common Stock outstanding as of August 10, 2026, as reported on comScore, Inc.'s (the "Issuer") 10-Q filed with the Securities and Exchange Commission ("SEC") on August 14, 2026, as increased by (i) 61,431 shares of Common Stock issuable upon settlement of deferred RSUs held by the Reporting Persons (as defined in Item 5), (ii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, and (iii) (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination.


SCHEDULE 13D




Comment for Type of Reporting Person:
Represents (i) 3,295,183 shares of Common Stock, (ii) 61,431 shares of Common Stock, issuable upon settlement of deferred RSUs, (iii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, (iv) 3,286,825 shares of Common Stock that were acquired in connection with the Combination (as defined and disclosed in Item 4) and (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination. Such shares of Common Stock represent approximately 63.7% of the Issuer's outstanding Common Stock, assuming settlement of the deferred RSUs held by the Reporting Persons and the exchange of all Series C Preferred Stock held by the Reporting Persons into shares of Common Stock, in accordance with Rule 13d-3 of the Act. However, pursuant to the Certificate of Designations, no holder of Series C Preferred Stock may convert Series C Preferred Stock in an amount that would cause such holder to beneficially own immediately following such conversion more than 49.99% of the then outstanding shares of Common Stock. Pursuant to the Certificate of Designations, to the extent that the Series C Preferred Stock and any shares of Common Stock held by the Reporting Person, together with certain transferees and affiliates, would represent voting rights with respect to more than the Voting Threshold, such Reporting Person will not be permitted to exercise the voting rights with respect to any shares of Series C Preferred Stock held by them in excess of the Voting Threshold and the Issuer shall exercise the voting rights with respect to such shares of Series C Preferred Stock in excess of the Voting Threshold in a neutral manner. Calculated based on 15,184,326 shares of Common Stock outstanding as of August 10, 2026, as reported on the Issuer's 10-Q filed with the SEC on August 14, 2026, as increased by (i) 61,431 shares of Common Stock issuable upon settlement of deferred RSUs held by the Reporting Persons (as defined in Item 5), (ii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, and (iii) (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination.


SCHEDULE 13D




Comment for Type of Reporting Person:
Represents (i) 3,295,183 shares of Common Stock, (ii) 61,431 shares of Common Stock, issuable upon settlement of deferred RSUs, (iii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, (iv) 3,286,825 shares of Common Stock that were acquired in connection with the Combination (as defined and disclosed in Item 4) and (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination. Such shares of Common Stock represent approximately 63.7% of the Issuer's outstanding Common Stock, assuming settlement of the deferred RSUs held by the Reporting Persons and the exchange of all Series C Preferred Stock held by the Reporting Persons into shares of Common Stock, in accordance with Rule 13d-3 of the Act. However, pursuant to the Certificate of Designations, no holder of Series C Preferred Stock may convert Series C Preferred Stock in an amount that would cause such holder to beneficially own immediately following such conversion more than 49.99% of the then outstanding shares of Common Stock. Pursuant to the Certificate of Designations, to the extent that the Series C Preferred Stock and any shares of Common Stock held by the Reporting Person, together with certain transferees and affiliates, would represent voting rights with respect to more than the Voting Threshold, such Reporting Person will not be permitted to exercise the voting rights with respect to any shares of Series C Preferred Stock held by them in excess of the Voting Threshold and the Issuer shall exercise the voting rights with respect to such shares of Series C Preferred Stock in excess of the Voting Threshold in a neutral manner. Calculated based on 15,184,326 shares of Common Stock outstanding as of August 10, 2026, as reported on the Issuer's 10-Q filed with the SEC on August 14, 2026, as increased by (i) 61,431 shares of Common Stock issuable upon settlement of deferred RSUs held by the Reporting Persons (as defined in Item 5), (ii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, and (iii) (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination.


SCHEDULE 13D




Comment for Type of Reporting Person:
Represents (i) 3,295,183 shares of Common Stock, (ii) 61,431 shares of Common Stock, issuable upon settlement of deferred RSUs, (iii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, (iv) 3,286,825 shares of Common Stock that were acquired in connection with the Combination (as defined and disclosed in Item 4) and (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination. Such shares of Common Stock represent approximately 63.7% of the Issuer's outstanding Common Stock, assuming settlement of the deferred RSUs held by the Reporting Persons and the exchange of all Series C Preferred Stock held by the Reporting Persons into shares of Common Stock, in accordance with Rule 13d-3 of the Act. However, pursuant to the Certificate of Designations, no holder of Series C Preferred Stock may convert Series C Preferred Stock in an amount that would cause such holder to beneficially own immediately following such conversion more than 49.99% of the then outstanding shares of Common Stock. Pursuant to the Certificate of Designations, to the extent that the Series C Preferred Stock and any shares of Common Stock held by the Reporting Person, together with certain transferees and affiliates, would represent voting rights with respect to more than the Voting Threshold, such Reporting Person will not be permitted to exercise the voting rights with respect to any shares of Series C Preferred Stock held by them in excess of the Voting Threshold and the Issuer shall exercise the voting rights with respect to such shares of Series C Preferred Stock in excess of the Voting Threshold in a neutral manner. Calculated based on 15,184,326 shares of Common Stock outstanding as of August 10, 2026, as reported on the Issuer's 10-Q filed with the SEC on August 14, 2026, as increased by (i) 61,431 shares of Common Stock issuable upon settlement of deferred RSUs held by the Reporting Persons (as defined in Item 5), (ii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, and (iii) (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination.


SCHEDULE 13D




Comment for Type of Reporting Person:
Represents (i) 3,295,183 shares of Common Stock, (ii) 61,431 shares of Common Stock, issuable upon settlement of deferred RSUs, (iii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, (iv) 3,286,825 shares of Common Stock that were acquired in connection with the Combination (as defined and disclosed in Item 4) and (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination. Such shares of Common Stock represent approximately 63.7% of the Issuer's outstanding Common Stock, assuming settlement of the deferred RSUs held by the Reporting Persons and the exchange of all Series C Preferred Stock held by the Reporting Persons into shares of Common Stock, in accordance with Rule 13d-3 of the Act. However, pursuant to the Certificate of Designations, no holder of Series C Preferred Stock may convert Series C Preferred Stock in an amount that would cause such holder to beneficially own immediately following such conversion more than 49.99% of the then outstanding shares of Common Stock. Pursuant to the Certificate of Designations, to the extent that the Series C Preferred Stock and any shares of Common Stock held by the Reporting Person, together with certain transferees and affiliates, would represent voting rights with respect to more than the Voting Threshold, such Reporting Person will not be permitted to exercise the voting rights with respect to any shares of Series C Preferred Stock held by them in excess of the Voting Threshold and the Issuer shall exercise the voting rights with respect to such shares of Series C Preferred Stock in excess of the Voting Threshold in a neutral manner. Calculated based on 15,184,326 shares of Common Stock outstanding as of August 10, 2026, as reported on the Issuer's 10-Q filed with the SEC on August 14, 2026, as increased by (i) 61,431 shares of Common Stock issuable upon settlement of deferred RSUs held by the Reporting Persons (as defined in Item 5), (ii) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock, and (iii) (v) 4,223,621 shares of Common Stock issuable upon conversion of 4,223,621 shares of Series C Preferred Stock that were acquired in connection with the Combination.


SCHEDULE 13D


 
Charter Communications, Inc.
 
Signature:/s/ Jessica M. Fischer
Name/Title:Jessica M. Fischer / Chief Financial Officer
Date:08/21/2026
 
CCH II, LLC
 
Signature:/s/ Jessica M. Fischer
Name/Title:Jessica M. Fischer / Chief Financial Officer
Date:08/21/2026
 
Charter Communications Holdings, LLC
 
Signature:/s/ Jessica M. Fischer
Name/Title:Jessica M. Fischer / Chief Financial Officer
Date:08/21/2026
 
Spectrum Management Holding Company, LLC
 
Signature:/s/ Jessica M. Fischer
Name/Title:Jessica M. Fischer / Chief Financial Officer
Date:08/21/2026
 
Charter Communications Holding Company, LLC
 
Signature:/s/ Jessica M. Fischer
Name/Title:Jessica M. Fischer / Chief Financial Officer
Date:08/21/2026